- Display 15 Products per page
Markets in Human Reproductive Medicine
Published: May 1, 2005 | Price: $3,500.00 – $7,000.00
This study provides a comprehensive analysis of available and emerging reproductive products and technologies related to contraception and infertility treatments. The goal of this study is to provide a comprehensive range of information from detailed product analyses through industry trends, and to quantify and qualify the market for hormonal contraceptives, infertility pharmaceuticals, and for assisted reproductive technologies. The report forecasts the following markets through 2008: The world market oral contraceptives The world market hormonal contraceptive devices The world market infertility...
The U.S. Market for Home Care Products, 4th Edition
Published: June 1, 2005 | Price: $3,500.00 – $7,000.00
The U.S. market for home care products and equipment continues to post steady gains, primarily as a result of the aging population and increasing shifts of chronic care patients from hospitals to home. In 2004, an estimated 16 million people received home health care in the United States, and most of these individuals also used associated home care products. Through 2009, the numbers of home care patients will continue to grow as patient lifespans are extended with more sophisticated medical...
U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays, 2nd Ed.
Published: June 1, 2005 | Price: $3,500.00 – $7,000.00
Analytical microchips continue to be among the fastest growing technology segments of the life sciences. The range of applications to which these miniature laboratories may be directed is very broad, covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. This completely updated 2nd edition of Kalorama’s popular 2003 study thoroughly...
The World Market for Neurotherapeutic Drugs
Published: September 1, 2005 | Price: $3,500.00 – $7,000.00
Management of both acute and chronic neurologic diseases can be challenging for both the patient and the health care provider. Many neurologic disorders involve progressive deterioration in physical and mental capabilities, which can be devastating to the patient and the patient’s family. In many respects, neurotherapeutics represent the largest as-yet untapped market in medicine. This Kalorama Information report focuses on several key product segments of neurotherapeutic treatment: Alzheimer’s Disease and Other Dementias Brain and Neurologic Cancers Brain Trauma and Stroke...
The U.S. Market For Cardiovascular Devices
Published: September 1, 2005 | Price: $3,500.00 – $7,000.00
This report considers the markets for therapeutic cardiovascular devices, such as prosthetic valves, pacemakers, stents, support devices, ICDs, VADs, and TAHs, in the United States as broken down into four major segments: cardiomyopathy/congestive heart failure arrhythmias arteriosclerosis (coronary artery disease), and valvular heart disease While there are other cardiovascular conditions that remain significant in the American population, e.g., stroke and myocardial infarction, these four conditions present the core conditions that lead to more serious cardiovascular accidents and death and present...
Worldwide Market for Cancer Diagnostics, The
Published: October 1, 2005 | Price: $3,500.00 – $7,000.00
Cancer, with its high prevalence and mortality rate, continues to rank among the world's deadliest and most costly diseases. According to the WHO, in 2003, about 25 million people live with cancer and nearly 11 million new cases are diagnosed each year. With advances in protein and cell chemistry, genetics and molecular biology researchers are making continued progress in understanding the disease. Further, cancer drug research is moving from traditional cytotoxic chemotherapies toward higher specificity immunological and biological approaches that...
World Market for Respiratory Equipment, The
Published: November 1, 2005 | Price: $3,500.00 – $7,000.00
Respiratory diseases are among the most common ailments across the world. Asthma and chronic obstructive pulmonary disease (COPD) are the major causes of mortality rates among children and elderly. Currently, about 300 million people suffer from asthma—the number only expected to rise over next few years—and about 14.2 million people suffer from COPD. Given these numbers, it’s no wonder that the market for respiratory products is buoyant. This report analyzes the worldwide market for respiratory disposables and reusables, including the...
Worldwide Market for Pediatric Drugs, 2nd Edition, The
Published: November 1, 2005 | Price: $3,500.00 – $7,000.00
Although, the next 15-20 years will shift a majority of the population into the elderly population group, children will continue to remain the bulk of the dependent population worldwide with 9 in every 10 people falling into a pediatric age range in the less developed regions of Africa, Asia and Latin America. Therefore, the treatment of conditions and diseases affecting pediatrics and the healthy growth of children are vital to providing a solid foundation for healthy adults in the future....
Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living, The
Published: January 1, 2006 | Price: $3,500.00 – $7,000.00
The U.S. long-term care industry experienced strong growth from 1999 through 2004 and this growth is expected to continue through the end of the decade. Indeed, the aging of the U.S. population will push unprecedented demand for all forms of long-term care, but ongoing cost containment issues continue to pressure both private and public managed care organizations and make competition in this dynamic environment challenging. This comprehensive study from Kalorama Information details four segments of the long-term care industry, including:...
The Impact of the Phase III Pipeline – Future Projections and Market Disruptions
Published: March 1, 2006 | Price: $3,500.00 – $7,000.00
There are hundreds of drugs in Phase III clinical trials, of which almost 200 of them may gain market approval from the FDA in the coming 5 years. Which drugs will make it and how these drugs impact existing pharmaceutical markets in terms of overall size and competitive share is one of the most difficult forecasting projects in market research. In this nearly 500-page analysis, Kalorama Information has compiled all the relevant information about the candidates, their value, and their...
HIV – A Strategic Analysis of Therapeutic and Testing Markets
Published: March 1, 2006 | Price: $3,500.00 – $7,000.00
The strategic interplay of of HIV/AIDS diagnostics and therapeutics is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS, companies must think on a global basis, and in addition to the basic pathology and complications of HIV/AIDS, there are societal and ethical pressures, geopolitical factors, and evolving marketplace disruptions. For the development of a coherent strategy in this therapeutic area, companies must clearly focus on three...
The Global Market for Adjunctive Therapies in Cancer, 2nd Edition
Published: April 1, 2006 | Price: $3,500.00 – $7,000.00
Adjunctive therapies are not only vital to the success of cancer treatments, enhancing compliance and outcomes, but they are also a dynamic area of research and development in a variety of disciplines from drug delivery to biologics. It also happens to be the largest portion of the overall cancer therapeutics market. This report provides the reader with a comprehensive analysis of the worldwide market for therapeutics to treat and manage symptoms in cancer patients. Market information, including market size and...
Medical and Biological Sensors and Sensor Systems – Markets, Applications, and Competitors Worldwide, 2nd Edition
Published: May 1, 2006 | Price: $3,500.00 – $7,000.00
The commercial world of medical sensors is vibrant and evolving rapidly. Reports that are only a year or two old are already out-of-date as new technologies make rapid penetration. This new edition attacks the field from the point of view of current R&D, technology and innovation, with an eye to potential markets and emerging technologies in clinical medicine, remote and military applications, process and materials quality control, environmental monitoring, and food and drug quality control. Technology trends and particulary significant...
Outsourcing in Drug Development: The Contract Research (CRO) Market, 2nd Edition
Published: May 1, 2006 | Price: $3,500.00 – $7,000.00
CRO is a need-to know practice in pharmaceutical marketing today; but information is not always easy to find. This second edition of Kalorama’s best-selling look at the clinical contract research industry provides the key information competitors need to navigate the complexities and costs of clinical research in the drug development process. In addition to a comprehensive discussion of the market and regulatory environment, the report details: the size and nature of the drug research pipeline, the size and growth of...
World Market for Prescription Respiratory Drugs, The
Published: October 1, 2006 | Price: $3,500.00 – $7,000.00
The global market for prescription respiratory drugs encompasses a wide variety of products that treat both common everyday respiratory illnesses as well as serious chronic conditions such as COPD. Technological developments and improved delivery methods have given many health professionals a wider range of products to treat patients with respiratory diseases and have expanded the market for respiratory pharmaceuticals. This comprehensive study of the market for prescription pharmaceutical products to treat respiratory illness examines six distinct drug segments: Anti-inflammatories, Inhaled...